Search for: "People v Lee" Results 21 - 40 of 1,748
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Dec 2024, 11:40 pm by Patti Waller
People infected with norovirus usually recover in two to three days without serious or long-term health effects. [read post]
18 Dec 2024, 3:29 am by jonathanturley
Funding of programs came from sources such as the Carnegie Institution, and the Rockefeller Foundation, As discussed in my book, The Indispensable Right,” Supreme Court Justice Oliver Wendell Holmes upheld such sterilizations in his infamous Buck v. [read post]
2 Dec 2024, 6:16 am by Adam Klasfeld
Barbara Lee of California took over as lead plaintiff after Thompson withdrew from the case, in order to chair the House Select Committee Investigating the Jan. 6 Attacks. [read post]
21 Nov 2024, 9:05 pm by Anagha Vasudevarao
Supreme Court ruling in Securities and Exchange Commission (SEC) v. [read post]
11 Nov 2024, 12:54 am by INFORRM
On 5 November 2024, the Court of Appeal heard the appeal in Salman Iqbal v Geo TV Limited. [read post]
17 Oct 2024, 4:32 am by Thomas Lee and Jesse Egbert
It says that a federal judge believes that lots of people find their use of language "sensible. [read post]
4 Oct 2024, 10:56 am by Adam Klasfeld
Note-1: Ex-Department of Justice official Jeff Clark, who was formerly CC4, was dropped in the superseding indictment as a co-conspirator following the Supreme Court’s ruling in Trump v. [read post]
4 Oct 2024, 5:07 am by Beatrice Yahia
Sui-Lee Wee reports for the New York Times. [read post]
1 Oct 2024, 10:26 am by Jacob Fishman
Laura Coordes, The Anti-Modification Rules’ Application to Mixed Property: “It depends on what the meaning of the word ‘is’ is”, 44 Bankruptcy Law Letter 1 (September 2024) Last May, in Lee v. [read post]
25 Sep 2024, 9:30 pm by ernst
Board of Education, 1954, and related cases; andCases concerning elections and voting rights in the 1940s and 1950s with one Alabama primary election case, Gray v. [read post]
25 Sep 2024, 7:57 am by Kristian Stout
Mike Lee (R-Utah),  proposes to streamline the approval process for biosimilar drugs by automatically deeming all FDA-approved biosimilars as interchangeable with their reference products. [read post]